bill: he is one of nearly 40 on the watch list arrested at the border so far this year. fiscal year 2023 which started in october, okay? your october, november, december, january, we re already at that number. the problem is growing under president biden. republicans today will begin the process trying to hold him accountable. dana: one hour from now house republicans hold the first hearing on the border crisis. the focus will be on smuggling and the influx of deadly fentanyl. bill: arizona sheriff mark dannels says the situation is untenable. i m coming to d.c. to address the reality of what s going on in our community, talk about the destruction and disarray and crisis on our border. there is no political spin. this is reality coming at them this morning. i appreciate chairman jordan bringing this committee together to address this today and have me here. i m looking forward to it. dana: former border patrol chief rodney scott is here in reaction. let s begin with
12 jurors saw the truth for what it was. i had a phenomenal legal team, probably the best criminal defense attorney in the country. thomas moore society led by peter bream were by me the whole way. bill: if the jury goes the other way you look at jail time. remarkable stuff there. i know you said you didn t want to get into it in your first answer. why do you think they came after you? i m a pro-lifeer and been an activist for 20 plus years and we all know what happened in june and we all know roe v. wade was overturned and does it sound like a coincidence? you know, i can t speculate but it seems too good to be true for me that the government would decide after 20 years this is the time to go after this man who has been peacefully protesting and praying for years. and all of a sudden in light of
Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure® Predict Prognostic Test for Alzheimer's Disease - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Diadem SpA, (or Diadem US, Inc.) a company developing the first blood-based test for the early prediction of progression to Alzheimer s disease.